FDA+ roundup: Sen. Burr on strength­en­ing FDA's readi­ness; ICH guide­line adop­tion; Long­time FDA lawyer re­tires and more

While prais­ing the FDA’s quick, ag­ile and fre­quent use of the emer­gency use path­way to au­tho­rize Covid-19 tests, drugs and vac­cines, the Sen­ate health com­mit­tee’ …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER